Abbott received FDA clearance for first commercially available lab-based blood test to help evaluate concussion
On Mar. 7, 2023, Abbott announced that it had received U.S. Food and Drug Administration clearance for what…
On Mar. 7, 2023, Abbott announced that it had received U.S. Food and Drug Administration clearance for what…
On Mar. 7, 2023, researchers at the National Institutes of Health reported the benefits of screening adult patients…
On Mar. 7, 2023, researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs…
On Mar. 6, 2023, Neuromod Devices announced that the US Food and Drug Administration (FDA) had granted De…
On Mar. 3, 2023, the Malawi Ministry of Health declared a cholera outbreak, following laboratory confirmation of a…
On Mar. 1, 2023, BioNTech and Pfizer announced that they had submitted an application to the U.S. Food…
On Feb. 23, 2023, the United Nations reported that every two minutes, a woman dies during pregnancy or…
On Feb. 21, 2023, Gilead Sciences announced positive data from three retrospective real-world studies which demonstrated that initiation…
On Feb. 16, 2023, National Institutes of Health (NIH) scientists announced they had developed and released an innovative…
On Feb. 15, 2023, Researchers from Southwest University in China have constructed the entire chromosomal-scale genome assembly and…
On Feb. 13, 2023, Equatorial Guinea today confirmed its first-ever outbreak of Marburg virus disease. Preliminary tests carried…
On Feb. 10, 2023, the U.S. Food and Drug Administration issued an emergency use authorization for the first…
On Feb. 7, 2023, an NIH funded study by University of North Carolina reported that Bivalent booster vaccines…
On Feb. 7, 2023, the U.S. Department of Agricultureメs Research Service announced that it was implementing a $300…
On Feb. 2, 2023, a team of researchers supported by the National Institutes of Health found evidence linking…
On Feb. 1, 2023, researchers funded by the National Institutes of Health announded they had developed a new…
On Jan. 26, 2023, the U.S. Food and Drug Administration revised the Emergency Use Authorization for Evusheld (tixagevimab…
Our Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
On Jan. 18, 2023, researchers at the U.S. Department of Agriculture’s Agricultural Research Service announced they had bred…
On Jan. 13, 2023, a team of researchers including faculty at the Translational Genomics Research Institute (TGen), part…
On Jan. 11, 2023, the U.S. Food and Drug Administration reported that a single booster dose with an…
On Jan. 10, 2023, the WHO announced that an estimated 5 million children died beforecoronavirus_omicron_illustrationeir fifth birthday and…
On Jan. 9, 2023, BD (Becton, Dickinson) and CerTest Biotec have announced Emergency Use Authorization (EUA) from the…
On Jan. 6, 2023, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway…
On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…
On Jan. 5, 2023, the National Institutes of Health, in collaboration with the Administration for Strategic Preparedness and…
On Jan. 5, 2023, National Institutes of Health researchers announded they had published an assessment of 13 studies…
On Jan. 4, 2023, a National Institutes of Health funded study reported that moderate levels of two outdoor…
Milestones in Polio illustrates the slow but steady advancements from its clinical description and discovery to widespread infection…
On Dec. 23, 2022, BioNTech and Fosun Pharmaceutical announced that they had received the certificates of registration as…